- Home
- AARD vs SNBR Comparison
AARD vs SNBR Comparison
Compare AARD & SNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- SNBR
- Stock Information
- Founded
- AARD 2017
- SNBR 1987
- Country
- AARD United States
- SNBR United States
- Employees
- AARD N/A
- SNBR N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- SNBR Home Furnishings
- Sector
- AARD Health Care
- SNBR Consumer Discretionary
- Exchange
- AARD Nasdaq
- SNBR Nasdaq
- Market Cap
- AARD 242.9M
- SNBR 213.8M
- IPO Year
- AARD 2025
- SNBR 1998
- Fundamental
- Price
- AARD $8.59
- SNBR $10.04
- Analyst Decision
- AARD Strong Buy
- SNBR Hold
- Analyst Count
- AARD 5
- SNBR 2
- Target Price
- AARD $32.60
- SNBR $9.00
- AVG Volume (30 Days)
- AARD 77.3K
- SNBR 711.6K
- Earning Date
- AARD 08-13-2025
- SNBR 10-29-2025
- Dividend Yield
- AARD N/A
- SNBR N/A
- EPS Growth
- AARD N/A
- SNBR N/A
- EPS
- AARD N/A
- SNBR N/A
- Revenue
- AARD N/A
- SNBR $1,524,620,000.00
- Revenue This Year
- AARD N/A
- SNBR N/A
- Revenue Next Year
- AARD N/A
- SNBR N/A
- P/E Ratio
- AARD N/A
- SNBR N/A
- Revenue Growth
- AARD N/A
- SNBR N/A
- 52 Week Low
- AARD $4.88
- SNBR $4.48
- 52 Week High
- AARD $19.58
- SNBR $20.75
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- SNBR 52.37
- Support Level
- AARD N/A
- SNBR $10.10
- Resistance Level
- AARD N/A
- SNBR $11.05
- Average True Range (ATR)
- AARD 0.00
- SNBR 0.81
- MACD
- AARD 0.00
- SNBR -0.10
- Stochastic Oscillator
- AARD 0.00
- SNBR 37.55
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.